The innovation problem: shortfall of public funding and private investments to support high impact preclinical R&D projects
25 May 2023
| Standards

Overview
Kevin Outterson, Executive Director of CARB X and Austin B. Fletcher Professor at Boston University presented 'The innovation problem: shortfall of public funding and private investments to support high impact preclinical R&D projects' at the GLG information session on the on the antibacterial pipeline and access crisis, 17 May 2023.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance